platinum-based chemotherapy Clinical Research Trials

Please select a valid location from the dropdown

Found 168 clinical trials

Platinum-Based Chemotherapy Plus Ramucirumab in Patients With Advanced NSCLC Who Have Progressed on First Line Anti-PD-1 Immunotherapy

This is a non-randomized, phase-II study of platinum doublet chemotherapy plus ramucirumab in patients with advanced NSCLC who have progressed on first line anti-PD-1 Immunotherapy. Up to 25 evaluable participants will be enrolled over a period of 2 years. Seven patients will be recruited at the first stage .Eligible patients …

cancer chemotherapy

cancer treatment

lung carcinoma

metastasis

secondary malignant neoplasm of liver

1 views
25 Jan, 2021
1 location

Durvalumab Plus Tremelimumab Combination Immunotherapy With or Without Weekly Paclitaxel in Patients With Advanced Biliary Tract Carcinoma (BTC) After Failure of Platinum-based Chemotherapy

in patients with advanced BTC after failure of platinum-based chemotherapy. On the 25th June 2019, the maximum DLT event number was reached (6/10) in the durvalumab plus tremelimumab

2 views
05 Feb, 2021
42 locations

Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based Chemotherapy

gefitinib 250mg in Chinese patients with IIIB or IV NSCLC after failure of platinum-based chemotherapy. Secondary objectives of the study are to obtain the preliminary information on efficacy

cancer chemotherapy

platinum-based chemotherapy

metastasis

gefitinib

pleural effusion

1 views
07 Nov, 2020
1 location

A Study of Maintenance Treatment With Fluzoparib in gBRCA/PALB2 Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy

disease has not progressed on first line platinum based chemotherapy.

blood test

cancer

pancreatic adenocarcinoma

measurable disease

palb2

0 views
01 Feb, 2021
23 locations

Durvalumab in Combination With Chemotherapy in Virus-infected Patients With Non-small Cell Lung Cancer

This is a phase II trial of durvalumab in combination of platinum-based chemotherapy. Patients with stage IV Non-Small-Cell-Lung Cancer (NSCLC) with human immunodeficiency virus (HIV) infection

0 views
26 Jan, 2021
2 locations

Study of Vactosertib in Combination With Durvalumab in Advanced NSCLC

who progressed following platinum-based chemotherapy.

durvalumab

pd-l1

platinum-based chemotherapy

measurable disease

2 views
23 Jan, 2021

A Clinical Study of Sintilimab Independently or in Combination With IBI310 (Anti-CTLA4) in Second-Line Cervical Cancer

first-line or above platinum-based chemotherapy

0 views
27 Jan, 2021
2 locations

Trial of Active Immunotherapy With Globo H-KLH (OPT-822/821) in Women Who Have Non-Progressive Ovarian Cancer

primary peritoneal cancer after cytoreductive surgery and platinum-based chemotherapy as initial treatment for primary disease or as salvage treatment for first relapse.

primary peritoneal carcinoma

peritoneal cancer

cytoreductive surgery

fallopian tube

platinum-based chemotherapy

36 views
07 Nov, 2020
1 location

Nivolumab in Combination With Plinabulin in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC)

non-small cell lung cancer with progression on or after platinum-based chemotherapy. Plinabulin inhibits tumor growth by targeting both new and existing blood vessels going to the tumor as well

squamous non-small cell lung cancer

measurable disease

systemic therapy

brain metastases

metastasis

0 views
01 Mar, 2021
1 location

Adjuvant Whole Abdominal Intensity Modulated Radiotherapy (IMRT) for High Risk Stage FIGO III Patients With Ovarian Cancer

The prognosis for patients with advanced epithelial ovarian cancer remains poor despite aggressive surgical resection and platinum-based chemotherapy. More than 60% of patients will

recurrent disease

paclitaxel

docetaxel

ovarian epithelial cancer

residual tumor

46 views
07 Nov, 2020
1 location

Filter By

Found 168 clinical trials